mutations supplied The reality that, as explained down below, CLL therapy is predicated around the existence or absence of those mutations. The present consensus is, apart from clonal mutations, subclonal mutations that has a variant allelic frequency ranging from five to 10% (and so down below the threshold of detection by typical molecular approa